• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情期间急性心肌梗死患者就诊延迟情况

Delays in Presentation in Patients With Acute Myocardial Infarction During the COVID-19 Pandemic.

作者信息

Aldujeli Ali, Hamadeh Anas, Briedis Kasparas, Tecson Kristen M, Rutland Joshua, Krivickas Zilvinas, Stiklioraitis Simas, Briede Kamilija, Aldujeili Montazar, Unikas Ramunas, Zaliaduonyte Diana, Zaliunas Remigijus, Vallabhan Ravi C, McCullough Peter A

机构信息

Lithuanian University of Health Sciences, Kaunas, Lithuania.

Baylor University Medical Center, Dallas, TX, USA.

出版信息

Cardiol Res. 2020 Dec;11(6):386-391. doi: 10.14740/cr1175. Epub 2020 Nov 2.

DOI:10.14740/cr1175
PMID:33224384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7666599/
Abstract

BACKGROUND

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, has had a major impact on the behavior of patients, as well as on the delivery of healthcare services. With older and more medically vulnerable people tending to stay at home to avoid contracting the virus, it is unclear how the behavior of people with acute myocardial infarction (AMI) has changed. The aim of this study was to determine if delays in presentation and healthcare service delivery for AMI exist during the COVID-19 pandemic compared to the same period a year prior.

METHODS

In this single-center, retrospective study, we evaluated patients admitted with ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) during early months of the COVID-19 pandemic (March 11, 2020 to April 20, 2020) compared to patients admitted with same diagnosis during the same period a year prior.

RESULTS

There were 30 and 62 patients who presented with NSTEMI in the pandemic and pre-pandemic eras, respectively. The median pain-to-door time was significantly larger during the pandemic compared to pre-pandemic era (1,885 (880, 5,732) vs. 606 (388, 944) min, P < 0.0001). There was a significant delay in door-to-reperfusion time during the pandemic with a median time of 332 (182, 581) vs. 194 (92, 329) min (P = 0.0371). There were 24 (80%) and 25 (42%) patients who presented after 12 h of pain onset in pandemic and pre-pandemic eras, respectively (P = 0.0006). There were 47 and 60 patients who presented with STEMI during the pandemic timeframe of study and pre-pandemic timeframe, respectively. The median pain-to-door time during the pandemic was significantly larger than that of the pre-pandemic (620 (255, 1,500) vs. 349 (146, 659) min, P = 0.0141). There were 22 (47%) and 14 (24%) patients who presented after 12 h of pain onset in the pandemic and pre-pandemic eras, respectively (P = 0.0127). There was not a significant delay in door-to-reperfusion time (P = 0.9833). There were no differences in in-hospital death, stroke, or length of hospitalization between early and late presenters, as well as between pandemic and pre-pandemic eras.

CONCLUSIONS

In conclusion, this study found that patients waited significantly longer during the pandemic to seek medical treatment for AMI compared to before the pandemic, and that pandemic-specific protocols may delay revascularization for NSTEMI patients. These findings resulted in more than a threefold increase from the onset of symptoms to revascularization increasing the risks for future complications such as left ventricular dysfunction and cardiovascular death. Efforts should be made to increase patients' awareness regarding consequences of delayed presentation, and to find a balance between hospital evaluation strategies and goals of minimizing total ischemic time.

摘要

背景

由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的2019冠状病毒病(COVID-19)大流行,对患者的行为以及医疗服务的提供产生了重大影响。由于年龄较大且医疗状况更脆弱的人群倾向于待在家中以避免感染病毒,急性心肌梗死(AMI)患者的行为发生了怎样的变化尚不清楚。本研究的目的是确定与一年前的同期相比,在COVID-19大流行期间,AMI患者就诊及医疗服务提供是否存在延迟。

方法

在这项单中心回顾性研究中,我们评估了在COVID-19大流行早期(2020年3月11日至2020年4月20日)因ST段抬高型心肌梗死(STEMI)或非ST段抬高型心肌梗死(NSTEMI)入院的患者,并与一年前同期因相同诊断入院的患者进行比较。

结果

在大流行期间和大流行前时期,分别有30例和62例患者表现为NSTEMI。与大流行前时期相比,大流行期间从疼痛发作到入院的中位时间显著更长(1,885(880, 5,732)分钟对606(388, 944)分钟,P < 0.0001)。大流行期间从入院到再灌注的时间存在显著延迟,中位时间为332(182, 581)分钟对194(92, 329)分钟(P = 0.0371)。在大流行期间和大流行前时期,分别有24例(80%)和25例(42%)患者在疼痛发作12小时后就诊(P = 0.0006)。在大流行研究时间段和大流行前时间段,分别有47例和60例患者表现为STEMI。大流行期间从疼痛发作到入院的中位时间显著长于大流行前(620(255, 1,500)分钟对349(146, 659)分钟,P = 0.0141)。在大流行期间和大流行前时期分别有22例(47%)和14例(24%)患者在疼痛发作12小时后就诊(P = 0.0127)。从入院到再灌注的时间没有显著延迟(P = 0.9833)。早期和晚期就诊者之间以及大流行期间和大流行前时期之间,在院内死亡、中风或住院时间方面没有差异。

结论

总之,本研究发现与大流行前相比,大流行期间患者因AMI寻求医疗治疗的等待时间显著更长,并且针对大流行的特定方案可能会延迟NSTEMI患者的血管重建。这些发现导致从症状发作到血管重建的时间增加了三倍多,增加了未来诸如左心室功能障碍和心血管死亡等并发症的风险。应努力提高患者对延迟就诊后果的认识,并在医院评估策略和尽量缩短总缺血时间的目标之间找到平衡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ac/7666599/85a912248192/cr-11-386-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ac/7666599/1202cab04196/cr-11-386-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ac/7666599/85a912248192/cr-11-386-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ac/7666599/1202cab04196/cr-11-386-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ac/7666599/85a912248192/cr-11-386-g002.jpg

相似文献

1
Delays in Presentation in Patients With Acute Myocardial Infarction During the COVID-19 Pandemic.新冠疫情期间急性心肌梗死患者就诊延迟情况
Cardiol Res. 2020 Dec;11(6):386-391. doi: 10.14740/cr1175. Epub 2020 Nov 2.
2
Impact of the COVID-19 Pandemic on Patient Delay and Clinical Outcomes for Patients With Acute Myocardial Infarction.COVID-19 大流行对急性心肌梗死患者的就诊延迟和临床结局的影响。
J Korean Med Sci. 2022 May 30;37(21):e167. doi: 10.3346/jkms.2022.37.e167.
3
Increased mortality and worse cardiac outcome of acute myocardial infarction during the early COVID-19 pandemic.新冠肺炎大流行早期急性心肌梗死患者的死亡率增加和心脏预后更差。
ESC Heart Fail. 2021 Feb;8(1):333-343. doi: 10.1002/ehf2.13075. Epub 2020 Dec 6.
4
Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: A nationwide study.COVID-19大流行期间急性心肌梗死的治疗延误及院内结局:一项全国性研究。
Anatol J Cardiol. 2020 Nov;24(5):334-342. doi: 10.14744/AnatolJCardiol.2020.98607.
5
Initial Single-Center ST-Segment Elevation Myocardial Infarction Experience in New York Before and During the COVID-19 Pandemic.在 COVID-19 大流行前后纽约的初始单中心 ST 段抬高型心肌梗死经验。
Cardiovasc Revasc Med. 2022 Jan;34:80-85. doi: 10.1016/j.carrev.2021.01.026. Epub 2021 Jan 26.
6
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub.COVID-19 大流行期间的 ST 段抬高型心肌梗死:区域性公共服务医疗中心的观察结果。
Circ Cardiovasc Interv. 2020 Aug;13(8):e009413. doi: 10.1161/CIRCINTERVENTIONS.120.009413. Epub 2020 Aug 14.
7
Impact of the COVID-19 Pandemic on ST-elevation Myocardial Infarction from a Single-center Experience in Tokyo.COVID-19 大流行对东京单中心 ST 段抬高型心肌梗死的影响。
Intern Med. 2021 Dec 1;60(23):3693-3700. doi: 10.2169/internalmedicine.8220-21. Epub 2021 Sep 25.
8
Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic.在 2019 冠状病毒病大流行期间急性心肌梗死的发病情况、治疗方法和结局。
JAMA Cardiol. 2020 Dec 1;5(12):1419-1424. doi: 10.1001/jamacardio.2020.3629.
9
In-Hospital Management and Outcomes of Acute Myocardial Infarction Before and During the Coronavirus Disease 2019 Pandemic.新冠肺炎疫情前后急性心肌梗死患者的院内管理和结局。
J Cardiovasc Pharmacol. 2020 Nov;76(5):540-548. doi: 10.1097/FJC.0000000000000909.
10
The impact of COVID-19 on short-term prognosis of ST-segment elevation myocardial infarction patients receiving primary percutaneous coronary intervention in Wuhan China.COVID-19 对中国武汉行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者短期预后的影响。
Rev Cardiovasc Med. 2021 Mar 30;22(1):247-256. doi: 10.31083/j.rcm.2021.01.243.

引用本文的文献

1
Variations in Poisoning Epidemiology and Management During the Initial COVID-19 Outbreak in a Taiwanese Emergency Department.台湾某急诊科在新冠疫情初期中毒流行病学及处理的变化
Int J Gen Med. 2025 Jun 14;18:3175-3183. doi: 10.2147/IJGM.S520738. eCollection 2025.
2
The impact of the COVID-19 pandemic on ST-segment elevation myocardial infarction treatment strategy and outcomes.2019年冠状病毒病大流行对ST段抬高型心肌梗死治疗策略及预后的影响。
Front Cardiovasc Med. 2025 Apr 16;12:1522661. doi: 10.3389/fcvm.2025.1522661. eCollection 2025.
3
Impact of the COVID-19 Pandemic on Children and Adolescents with New-Onset Type 1 Diabetes.

本文引用的文献

1
Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction.COVID-19 与 ST 段抬高型心肌梗死患者的特征和结局。
Am J Cardiol. 2020 Sep 15;131:1-6. doi: 10.1016/j.amjcard.2020.06.063. Epub 2020 Jul 3.
2
Considerations for Management of Acute Coronary Syndromes During the SARS-CoV-2 (COVID-19) Pandemic.急性冠状动脉综合征在 SARS-CoV-2(COVID-19)大流行期间的处理注意事项。
Am J Cardiol. 2020 Sep 15;131:115-119. doi: 10.1016/j.amjcard.2020.06.039. Epub 2020 Jun 30.
3
Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy.
2019年冠状病毒病大流行对新诊断1型糖尿病儿童及青少年的影响
Pediatr Diabetes. 2023 May 30;2023:7660985. doi: 10.1155/2023/7660985. eCollection 2023.
4
Trends and outcomes of heart failure hospitalizations during COVID-19 pandemic.2019冠状病毒病大流行期间心力衰竭住院治疗的趋势与结果
BMC Public Health. 2025 Mar 4;25(1):864. doi: 10.1186/s12889-025-21995-y.
5
Impacts of Avoiding Emergency Department Visits During the COVID-19 Pandemic Among Patients With Acute Ischemic Heart Events.新冠疫情期间急性缺血性心脏事件患者避免前往急诊科就诊的影响
Risk Manag Healthc Policy. 2025 Feb 27;18:569-578. doi: 10.2147/RMHP.S508088. eCollection 2025.
6
Door-to-balloon Time for ST-elevation MI in the Coronavirus Disease 2019 Era.2019年冠状病毒病时代ST段抬高型心肌梗死的门球时间
US Cardiol. 2021 Jul 14;15:e13. doi: 10.15420/usc.2021.05. eCollection 2021.
7
Increased Mortality in a Nationwide Study of Gastrointestinal Hospitalizations in the United States During the 2020 Coronavirus Pandemic.2020年冠状病毒大流行期间美国全国性胃肠道住院患者研究中的死亡率上升
Cureus. 2024 Aug 15;16(8):e66931. doi: 10.7759/cureus.66931. eCollection 2024 Aug.
8
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on the Severity and the Mortality of Acute Myocardial Infarction in Japan - Analysis From the JROAD-DPC Database.2019年冠状病毒病(COVID-19)大流行对日本急性心肌梗死严重程度和死亡率的影响——来自日本诊断程序组合数据库(JROAD-DPC)的分析
Circ Rep. 2024 May 9;6(6):191-200. doi: 10.1253/circrep.CR-24-0011. eCollection 2024 Jun 10.
9
Excess non-COVID-19-related mortality among inflammatory bowel disease decedents during the COVID-19 pandemic.COVID-19 大流行期间炎症性肠病死亡者的非 COVID-19 相关超额死亡率。
World J Gastroenterol. 2024 May 28;30(20):2677-2688. doi: 10.3748/wjg.v30.i20.2677.
10
Treatment seeking experiences of ACS patients in Yogyakarta, Indonesia during COVID-19 pandemic: A qualitative study.印度尼西亚日惹地区急性冠脉综合征患者在 COVID-19 大流行期间的求医经历:一项定性研究。
PLoS One. 2024 Apr 30;19(4):e0302320. doi: 10.1371/journal.pone.0302320. eCollection 2024.
意大利北部新冠疫情期间急性冠状动脉综合征住院率降低
N Engl J Med. 2020 Jul 2;383(1):88-89. doi: 10.1056/NEJMc2009166. Epub 2020 Apr 28.
4
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China.2019年冠状病毒病(COVID-19)疫情对中国香港ST段抬高型心肌梗死治疗的影响
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631. doi: 10.1161/CIRCOUTCOMES.120.006631. Epub 2020 Mar 17.
5
Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction.新冠疫情:由于传播、严重程度及应对不力处于“惊人水平”,世界卫生组织宣布其为大流行病。
BMJ. 2020 Mar 12;368:m1036. doi: 10.1136/bmj.m1036.
6
Fourth Universal Definition of Myocardial Infarction (2018).心肌梗死的第四次全球定义(2018年)。
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264. doi: 10.1016/j.jacc.2018.08.1038. Epub 2018 Aug 25.
7
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).2017年欧洲心脏病学会(ESC)ST段抬高型急性心肌梗死患者管理指南:欧洲心脏病学会(ESC)ST段抬高型急性心肌梗死患者管理工作组
Eur Heart J. 2018 Jan 7;39(2):119-177. doi: 10.1093/eurheartj/ehx393.
8
Delayed Care and Mortality Among Women and Men With Myocardial Infarction.心肌梗死后女性和男性的延迟治疗与死亡率。
J Am Heart Assoc. 2017 Aug 21;6(8):e005968. doi: 10.1161/JAHA.117.005968.
9
Delays in the treatment of patients with acute coronary syndrome: Focus on pre-hospital delays and non-ST-elevated myocardial infarction.急性冠状动脉综合征患者治疗的延误:关注院前延误及非ST段抬高型心肌梗死
Int J Cardiol. 2016 Oct 15;221:1061-6. doi: 10.1016/j.ijcard.2016.07.082. Epub 2016 Jul 16.
10
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation.2015年欧洲心脏病学会非持续性ST段抬高型急性冠状动脉综合征患者管理指南
Rev Esp Cardiol (Engl Ed). 2015 Dec;68(12):1125. doi: 10.1016/j.rec.2015.10.009.